Velez, Alejandro http://orcid.org/0000-0003-3533-1240
Kaul, Ajay
El-Chammas, Khalil I.
Knowlton, Lesley
Madis, Erick
Sahay, Rashmi
Fei, Lin
Stiehl, Sarah
Santucci, Neha R.
Funding for this research was provided by:
Cincinnati Children's Hospital Medical Center
Article History
Accepted: 6 December 2023
First Online: 4 January 2024
Declarations
:
: This study was funded by pediatric gastroenterology divisional funds.
: All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.
: This retrospective chart review study involving human participants was done in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Human Investigation Committee (IRB) of the Cincinnati Children’s Hospital approved this study.
: Not applicable.
: Not applicable.
: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
: All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Lesley Knowlton, Erick Madis, and Alejandro Velez Lopez supervised by Dr. Neha R Santucci. Dr. Rashmi Sahay provided statistical expertise, Sarah Stiehl provided pharmaceutical expertise, while Drs. Kaul, El-Chammas and Santucci provided expertise on functional constipation and other motility disorders. The first draft of the manuscript was written by Alejandro Velez Lopez and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
: As an abstract/poster for the 2021 North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) that only included the prucalopride cohort results. As an abstract/poster for NASPGHAN 2022 that included the conventional therapy–prucalopride cohort analysis and the propensity matched data. As an abstract/podium presentation for 2022 Pediatric Colorectal and Pelvic Reconstruction Conference (PCPLC).